Latest Presentation
Latest Financial Results

Q3 2022
Quarter Ended September 30, 2022
Latest Annual Filing
For Fiscal Year Ending December 31, 2021
Report Links
Email Alerts
Sign up today and receive company updates straight to your inbox.

Company Overview
NightHawk Biosciences is a fully integrated biopharmaceutical to streamline the creation of innovative medical countermeasures, breaking through barriers that prolong drug development. Our ecosystem is driven by the discovery efforts of SkunkWorx Bio, Inc, the development and commercial expertise of Elusys Therapeutics, Inc., and our in-house contract research and development biomanufacturing organization (CDMO) Scorpius Biological Services. This empowers us to bring our ideas to life with efficient control, superior quality, and uncharacteristic agility.
IR Contacts
Headquarters
Nighthawk Biosciences, Inc.
627 Davis Drive
Suite 300
Morrisville, NC 27560
T: +1 919 240 7133
info@nighthawkbio.com
Investor Relations
Transfer Agent
Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
T: +1 212 509 4000